AGP Executive Report
Last update: 5 hours agoDrug Safety: Apothecary Pharma recalled compounded tirzepatide and NAD+ injections after it could not confirm the products were sterile; contamination has not been confirmed. The recall underscores the risks of compounded medicines, which aren’t reviewed by the FDA for safety or quality before sale. Medication Warnings: The UK medicines regulator is strengthening antidepressant warnings about suicidal thoughts and sexual dysfunction, including symptoms that may continue after treatment ends. Coverage Access: Washington officials estimate about 250,000 people could lose Medicaid when new work-reporting rules begin in January, potentially disrupting prescriptions and ongoing care. Humanitarian Aid: WHO delivered 71 tonnes of medical supplies to conflict-hit northern Ethiopia, where health services face severe shortages.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
